Specifically, by promoting the expression of serum response factor (SRF) in an m6A-dependent manner via impairing the miRNA-dependent decay of the SRF mRNA, IGF2BP1 promotes SRF-dependent transcription in cancer, thereby enhancing tumor cell growth and invasion. Here, SRF is linked to cancer.